Free Trial

Dynatronics (DYNT) Competitors

Dynatronics logo
$0.08 +0.00 (+0.50%)
As of 08/1/2025 02:20 PM Eastern

DYNT vs. NDRA, CHEK, BLAC, HSCS, XAGE, VERO, AMIX, TIVC, GCTK, and AEMD

Should you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include ENDRA Life Sciences (NDRA), Check-Cap (CHEK), Bellevue Life Sciences Acquisition (BLAC), HeartSciences (HSCS), Longevity Health (XAGE), Venus Concept (VERO), Autonomix Medical (AMIX), Tivic Health Systems (TIVC), GlucoTrack (GCTK), and Aethlon Medical (AEMD). These companies are all part of the "medical equipment" industry.

Dynatronics vs. Its Competitors

ENDRA Life Sciences (NASDAQ:NDRA) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

Dynatronics has higher revenue and earnings than ENDRA Life Sciences. Dynatronics is trading at a lower price-to-earnings ratio than ENDRA Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ENDRA Life SciencesN/AN/A-$11.51M-$172.04-0.03
Dynatronics$33.60M0.03-$2.70M-$0.78-0.10

ENDRA Life Sciences has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat ENDRA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ENDRA Life SciencesN/A -140.96% -106.14%
Dynatronics -8.35%-41.81%-9.56%

ENDRA Life Sciences presently has a consensus target price of $50.00, indicating a potential upside of 933.06%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe ENDRA Life Sciences is more favorable than Dynatronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ENDRA Life Sciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 0.0% of ENDRA Life Sciences shares are owned by insiders. Comparatively, 8.0% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ENDRA Life Sciences has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.

In the previous week, ENDRA Life Sciences had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for ENDRA Life Sciences and 0 mentions for Dynatronics. Dynatronics' average media sentiment score of 0.00 beat ENDRA Life Sciences' score of -1.00 indicating that Dynatronics is being referred to more favorably in the news media.

Company Overall Sentiment
ENDRA Life Sciences Negative
Dynatronics Neutral

Summary

Dynatronics beats ENDRA Life Sciences on 9 of the 15 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DYNT vs. The Competition

MetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.06M$65.47M$5.49B$9.54B
Dividend YieldN/AN/A4.73%4.09%
P/E Ratio-0.106.2128.8323.83
Price / Sales0.03109.49372.0766.02
Price / CashN/A18.4135.4557.96
Price / Book0.147.368.275.54
Net Income-$2.70M-$25.86M$3.25B$259.28M
7 Day PerformanceN/A-7.07%-3.73%-4.68%
1 Month PerformanceN/A2.26%4.29%4.36%
1 Year PerformanceN/A46.72%25.87%17.88%

Dynatronics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DYNT
Dynatronics
N/A$0.08
+0.5%
N/A-63.6%$1.06M$33.60M-0.10200Gap Up
NDRA
ENDRA Life Sciences
1.4453 of 5 stars
$5.91
-7.0%
$50.00
+746.7%
-99.9%$4.43MN/A-0.0320Negative News
Short Interest ↑
Gap Down
CHEK
Check-Cap
N/A$0.73
-2.3%
N/A-66.1%$4.27MN/A-0.2480Gap Down
BLAC
Bellevue Life Sciences Acquisition
N/A$0.94
-3.7%
N/A-93.6%$3.81MN/A0.00N/AHigh Trading Volume
HSCS
HeartSciences
2.287 of 5 stars
$3.53
-0.3%
$13.00
+268.4%
-21.6%$3.81MN/A-0.3810News Coverage
Upcoming Earnings
XAGE
Longevity Health
N/A$3.72
-4.9%
N/AN/A$3.72M$50K0.0014News Coverage
VERO
Venus Concept
1.3157 of 5 stars
$2.51
-1.4%
N/A-66.2%$3.57M$61.00M-0.03410Positive News
AMIX
Autonomix Medical
3.1601 of 5 stars
$1.24
-5.7%
$16.50
+1,236.0%
-93.3%$3.43MN/A-0.171Gap Down
High Trading Volume
TIVC
Tivic Health Systems
0.6315 of 5 stars
$3.65
-8.1%
N/A-71.4%$3.21M$780K0.0010Positive News
GCTK
GlucoTrack
0.2626 of 5 stars
$6.57
-4.1%
N/A-99.6%$3.17MN/A-0.125News Coverage
Positive News
AEMD
Aethlon Medical
1.3852 of 5 stars
$1.21
-5.5%
$56.00
+4,528.1%
-56.3%$3.14M$570K-0.1010Positive News
Gap Down

Related Companies and Tools


This page (NASDAQ:DYNT) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners